{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:48:33Z","timestamp":1787024913960,"version":"build-2736575974"},"reference-count":32,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Internet Res"],"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n Malignant hyperthermia (MH) seriously threatens perioperative safety. Historically, limited awareness of MH among anesthesiologists and the unavailability of dantrolene have caused a high mortality rate of MH events in China. Although domestic dantrolene has been available in China since 2020, Chinese anesthesiologists continue to face significant challenges in managing MH crises. A WeChat applet\u2013based National Remote Emergency System for Malignant Hyperthermia (MH-NRES) was developed to assist anesthesiologists in making rapid diagnosis, initiating dantrolene mobilization, implementing effective treatment, and subsequently constructing an MH database. However, the effectiveness of MH-NRES in real-world patients experiencing MH in China remains uncertain.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n This study aimed to assess the effectiveness of MH-NRES in enhancing outcomes for patients with MH.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n A retrospective pre-post implementation study was conducted from January 2018 to November 2024. The MH-NRES intervention was initiated in December 2022. Medical records were reviewed both before and after the implementation of our intervention, encompassing demographic characteristics, anesthesia-related data, treatment details, and clinical outcomes. Descriptive analyses and a pre-post intervention comparison were used to assess the effectiveness of the MH-NRES intervention. The primary outcome was the mortality of patients with MH. The use of dantrolene and the time interval from the MH episode to the administration of dantrolene were considered secondary outcomes. The user activity metrics of MH-NRES were also reported.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n After the MH-NRES was launched for public use, the cumulative number of users reached 21,835, with a maximum daily user growth of 689 (median 15, IQR 9\u201025). The cumulative page views amounted to 245,740 and the average daily page views were 262.8. A total of 34 patients with MH and 14 patients with MH were retrospectively collected before and after the intervention, respectively. The mortality of patients with MH in the postimplementation group was significantly lower compared with that in the preimplementation group (1\/14, 7.1% vs 19\/34, 55.9%;\n P<\/jats:italic>\n =.002). No significant differences were observed in the early clinical manifestations of MH between the 2 groups. The rate of dantrolene use in the postimplementation group was significantly higher than that in the preimplementation group (11\/14, 78.6% vs 15\/34, 44.1%;\n P<\/jats:italic>\n =.03). The dantrolene available time in the postimplementation group was 126.5 minutes earlier than that in the preimplementation group, but the difference did not reach statistical significance (median 113.5, IQR 54.5\u2010244.3 vs 240, IQR 105-324 minutes,\n P<\/jats:italic>\n =.08).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n The MH-NRES aids in improving the timely administration of dantrolene and decreasing mortality rates among patients with MH. This system represents a rare disease perioperative management model and constitutes a specialized perioperative management approach for rare diseases that suits the current medical situation in China.<\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/71476","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T12:05:06Z","timestamp":1746446706000},"page":"e71476-e71476","source":"Crossref","is-referenced-by-count":1,"title":["The Effectiveness of a Mobile National Remote Emergency System for Malignant Hyperthermia in China: Retrospective Pre-Post Implementation Study"],"prefix":"10.2196","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8798-9063","authenticated-orcid":false,"given":"Lingcan","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0084-3318","authenticated-orcid":false,"given":"Hong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3539-5706","authenticated-orcid":false,"given":"Yunxia","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5503-0053","authenticated-orcid":false,"given":"Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9196-1736","authenticated-orcid":false,"given":"Tao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6694-8513","authenticated-orcid":false,"given":"Xiaoqian","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-015-0310-1","article-title":"Malignant hyperthermia: a review","volume":"10","author":"Rosenberg","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"R2","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1213\/ANE.0000000000004039","article-title":"Consensus statement of the malignant hyperthermia association of the United States on unresolved clinical questions concerning the management of patients with malignant hyperthermia","volume":"128","author":"Litman","journal-title":"Anesth Analg"},{"issue":"4","key":"R3","doi-asserted-by":"publisher","DOI":"10.1007\/s44254-023-00030-6","article-title":"The 100 most cited articles in malignant hyperthermia","volume":"1","author":"Han","journal-title":"Anesthesiology and Perioperative Science"},{"issue":"1","key":"R4","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.bja.2020.09.029","article-title":"Consensus guidelines on perioperative management of malignant hyperthermia suspected or susceptible patients from the European Malignant Hyperthermia Group","volume":"126","author":"R\u00fcffert","journal-title":"Br J Anaesth"},{"issue":"5","key":"R5","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1111\/anae.15317","article-title":"Malignant hyperthermia 2020: guideline from the association of anaesthetists","volume":"76","author":"Hopkins","journal-title":"Anaesthesia"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.2147\/JMDH.S387025","article-title":"The knowledge profile, competence and pending problems of Chinese anesthesiologists in dealing with malignant hyperthermia: a cross-sectional survey","volume":"16","author":"Tan","journal-title":"J Multidiscip Healthc"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.2147\/RMHP.S454895","article-title":"The anesthesiologists\u2019 perception of malignant hyperthermia and availability of dantrolene in China: a cross-sectional survey","volume":"17","author":"Wang","journal-title":"Risk Manag Healthc Policy"},{"issue":"1","key":"R8","doi-asserted-by":"publisher","DOI":"10.1186\/s12871-021-01328-3","article-title":"Malignant hyperthermia when dantrolene is not readily available","volume":"21","author":"Gong","journal-title":"BMC Anesthesiol"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.2147\/JMDH.S387208","article-title":"Clinical features of suspected malignant hyperthermia in China from 2015 to 2020: a retrospective study from China malignant hyperthermia emergency assistance group","volume":"15","author":"Tan","journal-title":"J Multidiscip Healthc"},{"issue":"1","key":"R10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/ALN.0000000000002490","article-title":"Succinylcholine use and dantrolene availability for malignant hyperthermia treatment: database analyses and systematic review","volume":"130","author":"Larach","journal-title":"Anesthesiology"},{"issue":"5","key":"R11","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1093\/bja\/aex331","article-title":"Evaluation of postoperative recovery in day surgery patients using a mobile phone application: a multicentre randomized trial","volume":"119","author":"Jaensson","journal-title":"Br J Anaesth"},{"issue":"6","key":"R12","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.bja.2022.02.038","article-title":"A mobile application to facilitate implementation of programmatic assessment in anaesthesia training","volume":"128","author":"Marty","journal-title":"Br J Anaesth"},{"issue":"5","key":"R13","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.bja.2024.01.014","article-title":"Digital health interventions for postoperative recovery in children: a systematic review","volume":"132","author":"Plummer","journal-title":"Br J Anaesth"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.2196\/46910","article-title":"Mobile prenatal education and its impact on reducing adverse pregnancy outcomes: retrospective real-world study","volume":"11","author":"Hao","journal-title":"JMIR Mhealth Uhealth"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.2196\/38680","article-title":"Effectiveness of the lilly connected care program in improving glycemic management among patients with type 2 diabetes in china: retrospective real-world study","volume":"25","author":"Su","journal-title":"J Med Internet Res"},{"issue":"1","key":"R16","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-022-02388-5","article-title":"What role can decentralized trial designs play to improve rare disease studies?","volume":"17","author":"Moore","journal-title":"Orphanet J Rare Dis"},{"issue":"12","key":"R17","doi-asserted-by":"publisher","DOI":"10.2196\/42084","article-title":"Perspectives of rare disease social media group participants on engaging with genetic counselors: mixed methods study","volume":"24","author":"Yabumoto","journal-title":"J Med Internet Res"},{"issue":"6","key":"R18","doi-asserted-by":"publisher","DOI":"10.2196\/16497","article-title":"mHealth app prescription in Australian general practice: pre-post study","volume":"8","author":"Byambasuren","journal-title":"JMIR Mhealth Uhealth"},{"issue":"6","key":"R19","doi-asserted-by":"publisher","DOI":"10.2196\/37084","article-title":"The first national remote emergency system for malignant hyperthermia (MH-NRES) in China: protocol for the design, development, and evaluation of a WeChat applet","volume":"11","author":"Yu","journal-title":"JMIR Res Protoc"},{"issue":"6","key":"R20","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1097\/ALN.0000000000004892","article-title":"Improving dantrolene mobilization in regions with limited availability","volume":"140","author":"Yu","journal-title":"Anesthesiology"},{"issue":"1","key":"R21","doi-asserted-by":"publisher","DOI":"10.1186\/s12911-023-02275-4","article-title":"A WeChat applet-based national remote emergency system for malignant hyperthermia in China: a usability study","volume":"23","author":"Yu","journal-title":"BMC Med Inform Decis Mak"},{"issue":"16","key":"R22","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000037699","article-title":"Diagnosis and rescue of malignant hyperthermia induced by anesthesia during radical surgery in a cervical cancer patient using the national remote emergency system: a case report","volume":"103","author":"Xiao","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"R23","doi-asserted-by":"publisher","DOI":"10.2196\/36691","article-title":"Mobile apps for people with rare diseases: review and quality assessment using mobile app rating scale","volume":"24","author":"Hatem","journal-title":"J Med Internet Res"},{"issue":"9","key":"R24","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-060394","article-title":"Needs of people with rare diseases that can be supported by electronic resources: a scoping review","volume":"12","author":"Long","journal-title":"BMJ Open"},{"issue":"6","key":"R25","doi-asserted-by":"publisher","first-page":"101760","DOI":"10.1016\/j.clinre.2021.101760","article-title":"Mobile app requirements for patients with RARE LIVER diseases: a single center survey for the ERN RARE-LIVER\u202c\u202c\u202c","volume":"45","author":"R\u00fcther","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"36","key":"R26","doi-asserted-by":"publisher","first-page":"5257","DOI":"10.1016\/j.vaccine.2019.07.062","article-title":"Effect of mobile phone text messaging for improving the uptake of influenza vaccination in patients with rare diseases","volume":"37","author":"Esteban-Vasallo","journal-title":"Vaccine (Auckl)"},{"issue":"1","key":"R27","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-020-01364-1","article-title":"LipoDDx: a mobile application for identification of rare lipodystrophy syndromes","volume":"15","author":"Ara\u00fajo-Vilar","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"R28","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1213\/ANE.0000000000000421","article-title":"Malignant hyperthermia deaths related to inadequate temperature monitoring, 2007-2012: a report from the North American malignant hyperthermia registry of the malignant hyperthermia association of the United States","volume":"119","author":"Larach","journal-title":"Anesth Analg"},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinane.2017.03.016","article-title":"Prevalence of malignant hyperthermia diagnosis in hospital discharge records in California, Florida, New York, and Wisconsin","volume":"39","author":"Lu","journal-title":"J Clin Anesth"},{"issue":"2","key":"R30","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1213\/ANE.0000000000004257","article-title":"Malignant hyperthermia\u2013susceptible adult patient and ambulatory surgery center: society for ambulatory anesthesia and ambulatory surgical care committee of the American Society of Anesthesiologists position statement","volume":"129","author":"Urman","journal-title":"Anesth Analg"},{"key":"R31","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-9-8","article-title":"Functional and genetic characterization of clinical malignant hyperthermia crises: a multi-centre study","volume":"9","author":"Klingler","journal-title":"Orphanet J Rare Dis"},{"key":"R32","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/8340209","article-title":"Rapid dantrolene administration with body temperature monitoring is associated with decreased mortality in Japanese malignant hyperthermia events","volume":"2023","author":"Toyota","journal-title":"Biomed Res Int"}],"container-title":["Journal of Medical Internet Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jmir.org\/2025\/1\/e71476","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:00:52Z","timestamp":1782842452000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jmir.org\/2025\/1\/e71476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":32,"URL":"https:\/\/doi.org\/10.2196\/71476","relation":{},"ISSN":["1438-8871"],"issn-type":[{"value":"1438-8871","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,14]]},"article-number":"v27i4e71476"}}